David Patience Accelerate Diagnostics, Inc (AXDX) insider trading activity

AXDX Quotes by TradingView

David Patience is Chief Financial Officer of Accelerate Diagnostics, Inc. Currently has a direct ownership of 50,419 shares of AXDX, which is worth approximately $97,308. The most recent transaction as insider was on Apr 09, 2024, when has been sold 13,296 shares (Common Stock) at a price of $0.87 per share, resulting in proceeds of $11,567. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50.4K
0% 3M change
495.76% 12M change
Total Value Held $97,308

David Patience Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 09 2024
SELL
Open market or private sale
$11,567 $0.87 p/Share
13,296 Reduced 20.87%
50,419 Common Stock
Apr 09 2024
BUY
Exercise of conversion of derivative security
-
37,468 Added 37.03%
63,715 Common Stock
Feb 26 2024
SELL
Open market or private sale
$336 $0.96 p/Share
350 Reduced 1.32%
26,247 Common Stock
Feb 26 2024
BUY
Exercise of conversion of derivative security
-
1,000 Added 3.62%
26,597 Common Stock
Jan 23 2024
BUY
Grant, award, or other acquisition
-
16,666 Added 39.43%
25,597 Common Stock
Dec 13 2023
SELL
Open market or private sale
$425 $4.39 p/Share
97 Reduced 1.07%
8,931 Common Stock
Dec 13 2023
BUY
Exercise of conversion of derivative security
-
331 Added 3.54%
9,028 Common Stock
Nov 13 2023
SELL
Open market or private sale
$540 $5.57 p/Share
97 Reduced 1.1%
8,697 Common Stock
Nov 13 2023
BUY
Exercise of conversion of derivative security
-
331 Added 3.63%
8,794 Common Stock
Oct 13 2023
SELL
Open market or private sale
$559 $5.83 p/Share
96 Reduced 1.12%
8,463 Common Stock
Oct 13 2023
BUY
Exercise of conversion of derivative security
-
331 Added 3.72%
8,559 Common Stock
Sep 13 2023
SELL
Open market or private sale
$626 $6.53 p/Share
96 Reduced 1.15%
8,228 Common Stock
Sep 13 2023
BUY
Exercise of conversion of derivative security
-
331 Added 3.82%
8,324 Common Stock
Aug 14 2023
SELL
Open market or private sale
$646 $6.8 p/Share
95 Reduced 1.17%
7,993 Common Stock
Aug 13 2023
BUY
Exercise of conversion of derivative security
-
331 Added 3.93%
8,088 Common Stock
Jul 13 2023
SELL
Open market or private sale
$634 $6.9 p/Share
92 Reduced 1.17%
7,757 Common Stock
Jul 13 2023
BUY
Exercise of conversion of derivative security
-
330 Added 4.03%
7,849 Common Stock
Jun 13 2023
SELL
Open market or private sale
$1,158 $0.9 p/Share
1,287 Reduced 1.68%
75,192 Common Stock
Jun 13 2023
BUY
Exercise of conversion of derivative security
-
3,309 Added 4.15%
76,479 Common Stock
May 15 2023
SELL
Open market or private sale
$843 $0.69 p/Share
1,222 Reduced 1.64%
73,170 Common Stock
May 15 2023
BUY
Exercise of conversion of derivative security
-
3,309 Added 4.26%
74,392 Common Stock
Apr 13 2023
SELL
Open market or private sale
$745 $0.65 p/Share
1,147 Reduced 1.59%
71,083 Common Stock
Apr 13 2023
BUY
Exercise of conversion of derivative security
-
3,309 Added 4.38%
72,230 Common Stock
DP

David Patience

Chief Financial Officer
Tucson, AZ

Track Institutional and Insider Activities on AXDX

Follow Accelerate Diagnostics, Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXDX shares.

Notify only if

Insider Trading

Get notified when an Accelerate Diagnostics, Inc insider buys or sells AXDX shares.

Notify only if

News

Receive news related to Accelerate Diagnostics, Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AXDX